Atlas Trials

PK and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the US

Clinical trial NCT04582266 · COMPLETED

Trial details

NCT number
NCT04582266
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Study type
OBSERVATIONAL
COVID-19
Start date
2021-03-31
Primary completion
2022-04-13
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.